Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour

May 27, 2021 updated by: Jouni Ahonen, Helsinki University Central Hospital
In this study the analgesic effect of two different opioids (fentanyl and sufentanil) will be compared when given either intrathecally or epidurally in primiparous parturients during early phase of the labour.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Uusimaa
      • Helsinki, Uusimaa, Finland, FI-00610
        • Maternity Hospital, Helsinki University Central Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Primiparous parturients
  • In early phase of labour (cervical dilatation at or under 5 cm)
  • No prior opioids by any route of administration within past 120 min
  • Pain at or over 80 mm on 0-100 mm visual analog scale during contraction

Exclusion Criteria:

  • Allergy for any of the medications used
  • Contraindications for epidural/spinal analgesia
  • BMI at the time of delivery under 20 or over 35 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Spinal fentanyl
20 micrograms of intrathecally administered fentanyl in single dose. Total volume of intrathecal injection 2 ml.
Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique
Experimental: Epidural fentanyl
100 micrograms of epidurally administered fentanyl in a single dose. Total volume of epidural injection 7 ml.
Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.
Other Names:
  • labor epidural
  • labour epidural
Active Comparator: Spinal sufentanil
5 micrograms of intrathecally administered sufentanil in a single dose. Total volume of intrathecal injection 2 ml.
Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique
Experimental: Epidural sufentanil
20 micrograms of epidurally administered sufentanil in a single dose. Total volume of epidural injection 7 ml.
Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.
Other Names:
  • labor epidural
  • labour epidural

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Maximum Pain During Contraction at 20 Minutes After the Study Drug Delivery
Time Frame: 20 minutes
All parturients are to have a pain visual analog scale (VAS - on a 0-100 mm scale) at 80mm or higher before the initial study drug delivery. On this scale 0 mm presents a totally pain free condition while 100 mm presents the worst imaginable pain. The change of maximum pain in millimeters on the VAS scale during the 20 minutes following the study drug delivery will be recorded.
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Duration of Labour Analgesia After the Single Dose of Epidural or Intrathecal Opioid
Time Frame: The data below report an average duration of time that is typically less than three hours
The time from the study drug dose to the administration of next epidural bolus, up to five hours. After the study drug dose all parturients wil have epidural catheters in place for subsequent analgesia.
The data below report an average duration of time that is typically less than three hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Antti J Vaananen, M.D., Ph.D., Helsinki University Central Hospital (Katiloopiston sairaala)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

May 1, 2018

Study Registration Dates

First Submitted

August 26, 2016

First Submitted That Met QC Criteria

August 30, 2016

First Posted (Estimate)

August 31, 2016

Study Record Updates

Last Update Posted (Actual)

June 10, 2021

Last Update Submitted That Met QC Criteria

May 27, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • §12/19.6.2016/HUS/400/2016
  • 2016-000486-23 (EudraCT Number)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Pain

Clinical Trials on Spinal analgesia for labour pain

Subscribe